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Sudden, painless vision loss in patients with stroke risk factors is suspect for central retinal artery 
occlusion (CRAO), an ophthalmic emergency that in addition to ocular treatment warrants a thorough 
neurologic and vascular evaluation. In addition to the high risk of concurrent stroke, carotid artery 
stenosis and occlusion is often overlooked during the initial evaluation. Here we report a case of 
CRAO with concurrent ipsilateral complete left internal carotid artery (ICA) occlusion and right ICA 
critical narrowing, dissection and pseudoaneurysm, which subsequently improved with prompt 
hyperbaric oxygen therapy. [Clin Pract Cases Emerg Med. 2019;3(3):233-236.]
INTRODUCTION
Known commonly as a “stroke of the eye,” central retinal 
artery occlusion (CRAO) presents with sudden, severe, painless 
monocular visual loss, and is an ophthalmic emergency. While 
the presentation is rare (the incidence of CRAO is estimated 
around 1.9/100,000 in the United States) the consequences can 
be dire.1 The strong association between CRAO and stroke is 
well known, and prompt evaluation of the carotid arteries is 
paramount in order to expedite definitive treatment, especially 
since ipsilateral carotid artery disease is known to occur in 50% 
of these patients.2,3 
CASE REPORT
A 66-year-old male with known history of hypertension 
and hypothyroidism presented to the emergency department 
(ED) with sudden, painless loss of vision in his left eye of 
two hours duration. The patient reported that he had sneezed 
four times in rapid succession and then stated he lost vision 
in his left eye, but experienced no eye pain. The patient then 
drove himself to the ED. He denied any other accompanying 
symptoms on extensive review of systems. Examination 
revealed 20/30 vision in his right eye with corrective lenses 
(eyeglasses), but no light perception in his left. The left pupil 
did not have any direct light response but had preserved 
consensual response. Consensual light response was absent 
in the right pupil, but direct response was preserved. Point-
of-care ocular ultrasound was performed but did not reveal 
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any apparent abnormality. The patient had no other focal 
neurological deficits and was found to be in normal sinus 
rhythm on electrocardiogram. Tonometry was not available 
at this facility nor were ophthalmologic services. A head 
computed tomography (CT) without contrast showed no acute 
hemorrhage or apparent infarct and he was sent emergently to 
the ophthalmology clinic at the tertiary care hospital several 
miles away in consultation with the receiving ophthalmologist.
In the ophthalmology clinic, the patient was confirmed to 
have multiple arterial thrombi with characteristic cherry-red 
spot on exam consistent with CRAO. He was then transferred 
directly from the ophthalmology clinic to the hyperbaric 
chamber for hyperbaric oxygen therapy. Upon the initial dive 
at 33 feet of therapy he began seeing letters and his vision 
continued to improve after one hour at 60 feet. Vision in the 
affected eye improved from solely light perception to 20/50 
at 24 hours, with subsequent resolution of symptoms. Shortly 
thereafter, while inpatient he received CT angiography of the 
neck and head (Image), which revealed complete left internal 
carotid artery (ICA) occlusion at its origin with retrograde 
filling of the distal cervical and intracranial portions. The right 
ICA showed regions concerning for dissection with associated 
pseudoaneurysm formation, with another region just distal 
with critical narrowing of the cervical internal carotid artery to 
approximately one millimeter.
Several days later the patient underwent successful 
transcarotid artery revascularization in the operating room.
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What do we already know about this clinical 
entity? 
Central retinal artery occlusion is an 
ophthalmic emergency which requires both 
prompt neurologic and ophthalmic evaluation 
and advanced imaging.
What makes this presentation of disease 
reportable? 
Data on treatment efficacy for tissue 
plasminogen activator, hyperbaric treatment, 
and anterior chamber paracentesis is limited.
What is the major learning point? 
Hyperbaric oxygen therapy is an underutilized 
treatment, and if available, should be strongly 
considered within eight hours.
How might this improve emergency medicine 
practice? 
After central retinal artery occlusion is 
recognized, perform advanced imaging, and 
in conjunction with ophthalmic consultation, 
consider hyperbaric oxygen.
as soon as possible. In at least one study, 32% had acute or 
subacute brain infarct seen on imaging.11 Given the propensity 
for arterial occlusion and severe carotid stenosis (up to 40% 
of patients), we would recommend CT angiography of the 
neck and head be done as well, which is consistent with 
current guidelines.12 One study demonstrated that nine of 
nine patients with CRAO had angiographically demonstrable 
ipsilateral carotid artery disease.13 As magnetic resonance 
imaging is more time consuming, it was this team’s opinion 
that it could be done while inpatient.
Treatment for CRAO targets acute reperfusion of the central 
retinal artery; however, the exact choice of treatment is still a 
matter of debate. In this case, the physicians chose hyperbaric 
treatment and achieved vision recovery. The use of this modality 
is relatively rare; it is offered only 7% of the time, even though 
based on the American Heart Association classification of 
evidence, treatment of CRAO with hyperbaric oxygen therapy 
is Level IIb.14,15 Literature review demonstrates that overall 
65% of cases have shown improvement when treated with 
hyperbaric oxygen, although it is apparent that a significant 
portion of patients will benefit from oxygen alone. Given the 
relative ubiquity of supplemental oxygen and relatively low risk, 
Image. Computed tomography angiography of the head and neck 
in coronal (right) and axial (left) views demonstrating complete 
occlusion of the left internal carotid artery (ICA) (arrows) and 
critical narrowing of the right ICA (arrowhead), in a patient with 
right central retinal artery occlusion.
DISCUSSION
In the setting of sudden, painless vision loss, the 
diagnosis of CRAO must be at the top of the differential, as 
it portends the most vision- and life-threatening underlying 
diagnosis and with associated high mortality. Typical 
patients have severe monocular visual loss, with 80% of 
patients having a visual acuity of 20/400 or worse as a result 
of loss of blood supply to the inner retinal layers.4 Analogous 
to ischemic cerebral stroke, the pathology is thromboembolic 
and the majority are due to carotid artery disease, primarily 
due to atherosclerotic plaques. As demonstrated in this case, 
one cannot neglect carotid stenosis (and the heart) as other 
potential sources of emboli. 
Risk factors mimic those of cerebral stroke and include 
hypertension, diabetes mellitus, carotid artery disease, 
coronary artery disease, a history of transient ischemic attacks 
or cerebral vascular accidents, and smoking tobacco, among 
others.5 In fact, atherosclerotic disease is the leading cause 
of CRAO in patients aged 40-60 years.6 There have also been 
several case series of CRAO during and post angiography 
and stenting.7,8 Patients typically present with crippling 
monocular vision loss, and clinicians should focus on detailed 
ophthalmic and neurologic exams. As in this case, the classic 
“cattle trucking” or “box-carring,” which is a discontinuous 
appearance of the vessels due to segmentation of the blood 
column in the arteries, and the cherry-red spot in the macula, 
may be difficult to see without a dilated fundoscopic exam.8 
Given the emergent nature of the condition, swift imaging 
and treatment is critical. It is suspected that irreversible retinal 
damage occurs without recovery of vision within six and a 
half hours, although animal models show partial recovery 
only up to 240 minutes.9,10 Given these constraints, it is critical 
to obtain an expeditious CT to assess for intracranial infarct 
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it seems logical to place the patient on 100% oxygen by nasal 
cannula or non-rebreather upon presentation. However, if there 
is no significant improvement with normobaric oxygen within 
15 minutes, one algorithm proposes to proceed immediately to 
hyperbaric oxygen at two atmospheres of pressure.16 
As with most instances of ischemia, the colloquialism 
“time is vision” may apply here as well. Best outcomes 
likely result when applied within the first eight hours from 
the onset of visual impairment.17 The most widely studied 
treatment is tissue plasminogen activator, which binds to 
the site of the thrombus and facilitates the conversion of 
plasminogen to plasmin to dissolve the clot. Given the 
similarities between ischemic stroke and CRAO, it does 
seem biologically plausible it would be effective. It would 
appear, however, that data on the subject are mixed, with 
at least two large reviews demonstrating improvement of 
visual acuity as well as relative safety, and two other large 
multicenter randomized controlled trials failing to show the 
same but demonstrating severe side effects including the 
feared complication of intracranial hemorrhage.9,18-22 Another 
treatment that is well described and commonly used although 
its efficacy is unproven, is anterior chamber paracentesis. 
It functions to lower intraocular pressure to increase 
dilatation of the retinal arteries due to vascular tortuosity 
produced from distortion of the globe.23 Unfortunately, a 
2009 Cochrane review found no treatment modality is more 
effective than placebo.24  
Even after treatment, if any, these patients remain at high 
risk for ischemic stroke, with the incident rate ratio peaking at 
one to seven days after CRAO and remaining elevated for the 
first 30 days.25 
CONCLUSION
Prompt recognition of CRAO symptoms should be 
followed by a detailed neurologic and vascular evaluation 
for concurrent stroke and carotid artery stenosis or 
occlusion. These patients are also at risk for ischemic 
events after treatment, largely because atherosclerotic 
disease is the primary underlying diagnosis for both 
conditions. Hyperbaric oxygen is an underused treatment 
modality with promising results. Patients presenting to 
the ED within eight hours of symptom onset should be 
considered for this therapy. This case highlights the high 
risk to these patients, which requires intensive workup 
and admission from the ED and while inpatient, as well 
as provides further evidence for the successful use of 
hyperbaric oxygen treatment.
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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